IP Library Granted Patent US 8,064,988
Granted Patent B2
US 8,064,988 · App. 12/456,657 · Granted Nov 22, 2011

System for analyzing and treating abnormality of human and animal tissues

Assignee: NewLife Sciences, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,064,988
App. No.
12/456,657
Granted
Nov 22, 2011
Kind
B2
Abstract

A patient treatment unit for analyzing and treating abnormality of human or animal tissues, includes a display; a pulse generator circuit that outputs a sequence of electrical pulses at a pulse frequency, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses; a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator; and a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient.

Claims (37)

1. A patient treatment unit for analyzing and treating abnormality of human or animal tissues, comprising:

a display;

a pulse generator circuit that outputs a sequence of electrical pulses at a pulse frequency greater than 5 Hz, the electrical pulses having a pulse width less than 0.74 milliseconds, the peak voltage of the electrical pulses does not exceed about 120 volts; the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses, wherein the electrical pulses are substantially rectangular;

the pulse generator circuit further comprises current and voltage limiting means;

a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator each of the probes including an electrode, each of the electrodes separately connected to the patient treatment unit by first and second wires;

one of the electrodes includes a potentiometer for adjusting the intensity of the electrical pulses;

the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps when the probes are applied to the body of the patient;

the maximum charge of the electrical pulse does not exceed 7 micro-coulombs; and

a microcontroller for controlling the display.

2. The patient treatment unit of claim 1 , wherein the electrical pulses are substantially rectangular pulses when the probes have a substantially open circuit between them.

3. The patient treatment unit of claim 1 , wherein the pulse frequency is in a range of 1-490 Hz.+−0.6% from 500 ohms to 1 mega-ohm of resistance across the probes.

4. The patient treatment unit of claim 1 , wherein the pulse width is not less than 0.34 milliseconds and is not greater than 0.74 milliseconds.

5. The patient treatment unit of claim 1 , wherein a peak voltage of the electrical pulses across the probes when a 500 ohm resistance is present across the probes does not exceed about 4 volts.

6. The patient treatment unit of claim 1 , wherein a peak voltage of the electrical pulses across the probes when a 5 kilo-ohm resistance is present across the probes does not exceed about 30 volts.

7. The patient treatment unit of claim 1 , wherein a peak voltage of the electrical pulses across the probes when a 10 kilo-ohm resistance is present across the probes does not exceed about 40 volts.

8. The patient treatment unit of claim 1 , wherein one of the probes includes a potentiometer for adjusting a characteristic of the electrical pulses.

9. The patient treatment unit of claim 1 , wherein the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps.

10. The patient treatment unit of claim 1 , wherein the maximum charge of electrical pulse does not exceed 7 micro-coulombs.

11. The patient treatment unit of claim 1 , wherein the pulse generator circuit includes current and voltage limiting means.

12. The patient treatment unit of claim 1 , further comprising a microcontroller for controlling the display.

13. A patient treatment unit for analyzing and treating abnormality of human or animal tissues, comprising;

a display controlled by a microcontroller;

a pulse generator circuit including current and voltage limiting means, the pulse generator circuit outputting a sequence of electrical pulses at a pulse frequency not exceeding 1 GHz when treating a pain condition of a patient, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and pulse width of the electrical pulses, wherein the pulse width is not less than 0.34 milliseconds and is not greater than 0.74 milliseconds, wherein the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps, wherein the maximum charge of electrical pulse does not exceed 7 micro-coulombs;

a pair of probes for contacting a body of a patient and electrically couple to the pulse generator, wherein the electrical pulses are substantially rectangular pulses when the probes have a substantially open circuit between them, wherein one of the probes includes a potentiometer for adjusting a characteristic of the electrical pulses, each of the probes including an electrode, each of the electrodes separately connected to the patient treatment unit by respective first and second wires, the probes are configured to be applied to the skin of the body of the patient for relieving pain;

a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient, wherein a peak voltage of the electrical pulses across the probes when a 500 ohm resistance is present across the probes does not exceed about 4 volts; and

a circuit for detecting an overvoltage or overcurrent in the electrical pulses.

14. The patient treatment unit of claim 13 , wherein the pulse frequency is in a range of 1-490 Hz.+−0.6% from 500 ohms to 1 mega-ohm of resistance across the probes.

15. The patient treatment unit of claim 13 , wherein a peak voltage of the electrical pulses across the probes when a 5 kilo-ohm resistance is present across the probes does not exceed about 30 volts, and wherein a peak voltage of the electrical pulses across the probes when a 10 kilo-ohm resistance is present across the probes does not exceed about 40 volts.

16. The patient treatment unit of claim 14 , wherein a peak voltage of the electrical pulses across the probes when a 5 kilo-ohm resistance is present across the probes does not exceed about 30 volts, and wherein a peak voltage of the electrical pulses across the probes when a 10 kilo-ohm resistance is present across the probes does not exceed about 40 volts, and wherein the characteristic is the pulse frequency.

17. A patient treatment unit for analyzing and treating abnormality of human or animal tissues, comprising:

a display;

a microcontroller for controlling the display;

a pulse generator circuit that outputs a sequence of electrical pulses at a pulse frequency, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses, wherein the pulse generator circuit includes current and voltage limiting means;

a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator;

a circuit for detecting an overvoltage or an overcurrent in the electrical pulses; and

a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient, wherein one of the probes includes a potentiometer for adjusting the pulse frequency of the electrical pulses, wherein the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps.

18. The patient treatment unit of claim 1 , wherein the probes are configured to be applied to skin of the body of the patient for relieving pain, and wherein the current output of the pulse generator circuit exceeds 2 milliamps when the probes are applied to the body of the patient, and wherein the pulse frequency does not exceed 1 GHz when treating the pain condition of the patient.

Assignments (6)
SECURITY INTEREST Recorded Jun 5, 2026
From: TRUERELIEF, LLC
To: GLS HOLDINGS, LLC
Reel/Frame 074862/0970 →
SECURITY INTEREST Recorded Apr 21, 2026
From: TRUERELIEF, LLC
To: MEDCAP PARTNERS, LLC
Reel/Frame 074431/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: NEWLIFE SCIENCES LLC
To: TRUERELIEF, LLC
Reel/Frame 047711/0280 →
NOTICE OF LITIGATION Recorded Jun 7, 2010
From: WEINSTOCK, RONALD J.
To: NEW LIFE SCIENCES, LLC DBA SCIENTIFIC IMAGINETICS
Reel/Frame 024671/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2010
From: WEINSTOCK, RONALD J.
To: NEWLIFE SCIENCES LLC
Reel/Frame 024087/0922 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2010
From: WEINSTOCK, RONALD A.
To: NEWLIFE SCIENCES, LLC
Reel/Frame 023824/0244 →
Continuity (3)
Continuation 10856632 · May 28, 2004
Provisional Application 60474843 · Jun 2, 2003
Related Publication 20090270952A1 · Oct 29, 2009